secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tengjun Biotechnology Corp. (—)
CIK:        0001499785
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001213900-23-064063
Event type: leadership
Sentiment:  negative
Materiality: 0.85
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tengjun Biotechnology CEO/CFO/Director Xianchang Ma dies August 3, 2023
-----------------------------------------------------------------------

- Mr. Ma served as CEO, CFO, and Director since December 2019; no replacement announced.
- Company states it will update stockholders on further developments.
- The filing does not name an interim successor or provide transition plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1499785/000121390023064063/0001213900-23-064063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1499785/000121390023064063/ea182930-8k_tengjunbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-064063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer